https://www.selleckchem.com/pr....oducts/cm272-cm-272.
Immunomonitoring of chimeric antigen receptor (CAR) T cells relies primarily on their quantification in the peripheral blood, which inadequately quantifies their biodistribution and activation status in the tissues. Noninvasive molecular imaging of CAR T cells by PET is a promising approach with the ability to provide spatial, temporal, and functional information. Reported strategies rely on the incorporation of reporter transgenes or biolabeling, significantly limiting the application of CAR T-cell molecular imaging. In this study
Like
Comment
Share
